Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes.
Characterization and interpretation of disease-associated alterations of protein glycosylation are the central aims of the emerging glycoproteomics projects, which are expected to lead to more sensitive and specific diagnosis and improve therapeutic outcomes for various diseases. Here we report a new approach to identify carbohydrate-targeting serum biomarkers, termed isotopic glycosidase elution and labeling on lectin-column chromatography (IGEL). This technology is based on glycan structure-specific enrichment of glycopeptides by lectin-column chromatography and site-directed tagging of N-glycosylation sites by (18)O during the elution with N-glycosidase. The combination of IGEL with 8-plex isobaric tag for relative and absolute quantitation (iTRAQ) stable isotope labeling enabled us not only to identify N-glycosylation sites effectively but also to compare glycan structures on each glycosylation site quantitatively in a single LC/MS/MS analysis. We applied this method to eight sera from lung cancer patients and controls, and finally identified 107 glycopeptides in their sera, including A2GL_Asn151, A2GL_Asn290, CD14_Asn132, CO8A_Asn417, C163A_Asn64, TIMP1_Asn30, and TSP1_Asn1049 which showed the significant change of the affinity to Concanavalin A (ConA) lectin between the lung cancer samples and the controls (p < 0.05 and more than twofold change). These screening results were further confirmed by the conventional lectin-column chromatography and immunoblot analysis using additional serum samples. Our novel methodology, which should be valuable for diverse biomarker discoveries, can provide high-throughput and quantitative profiling of glycan structure alterations.
Ueda
Koji
K
Laboratory for Biomarker Development, Center for Genomic Medicine, RIKEN, Tokyo, Japan.
Takami
Sachiko
S
Saichi
Naomi
N
Daigo
Yataro
Y
Ishikawa
Nobuhisa
N
Kohno
Nobuoki
N
Katsumata
Masaru
M
Yamane
Akio
A
Ota
Minoru
M
Sato
Taka-Aki
TA
Nakamura
Yusuke
Y
Nakagawa
Hidewaki
H
D001798:Blood Proteins / Q000737:chemistry / Q000302:isolation & purification* / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D054794:Glycomics; D006031:Glycosylation; D011134:Polysaccharides / Q000737:chemistry / Q000302:isolation & purification*; D040901:Proteomics; D053719:Tandem Mass Spectrometry
D001798:Blood Proteins; D011134:Polysaccharides
Clin Cancer Res. 2007 Mar 15;13(6):1875-82
17363544
J Biol Chem. 1985 Jun 10;260(11):6882-7
3997852
FEBS Lett. 2009 Jun 5;583(11):1728-35
19328791
Nat Biotechnol. 2009 Apr;27(4):378-86
19349973
Rapid Commun Mass Spectrom. 2007;21(1):1-6
17125156
Methods Mol Biol. 2009;534:133-45
19277555
Nat Biotechnol. 2003 Jun;21(6):667-72
12754521
Nature. 2009 Jun 18;459(7249):1005-9
19421193
Nat Rev Cancer. 2005 Nov;5(11):845-56
16239904
J Lab Clin Med. 1999 Dec;134(6):599-604
10595787
Methods Mol Biol. 2009;534:5-21
19277556
Ann N Y Acad Sci. 2005 Jun;1043:817-23
16037309
Mol Cell Proteomics. 2009 May;8(5):883-6
19131327
Nat Protoc. 2007;2(2):334-9
17406594
Nat Protoc. 2006;1(6):3019-27
17406563
Methods Mol Biol. 2009;534:341-57
19277540
Med Res Rev. 2010 Mar;30(2):171-257
19291708
Biol Pharm Bull. 2009 May;32(5):796-800
19420744